Abstract

Coenzyme Q10 (CoQ10), a lipid involved in ATP synthesis, exhibits very limited oral absorption, and its endogenous production decreases with ageing and with the occurrence of oxidative stress. Our group previously showed that monoglycerides omega-3 (MAG-OM3) increase OM3 plasma concentrations. Since CoQ10 is liposoluble, we hypothesised that its 48 h pharmacokinetics is higher when provided with MAG-OM3 compared to CoQ10 alone (in powder form) or added to rice oil (a neutral triacylglycerol oil). A randomised triple-blind crossover study was performed with fifteen men and fifteen women consuming the three supplements providing 200 mg of CoQ10 in a random order. Blood samples were collected before (t = 0) and 1, 3, 5, 6, 7, 8, 10, 11, 24 and 48 h after the supplement intake. Plasma total CoQ10 concentrations were analysed on ultrahigh-performance liquid chromatography coupled to a tandem mass spectrometer (UPLC-MS/MS). Participants were 26⋅1 ± 4⋅8 years old. When CoQ10 was provided with rice or MAG-OM3 oils, the 48 h area under the curve (AUC 0-48 h) was approximately two times higher compared to when provided without an oil. The delta max concentration (ΔC max) of plasma CoQ10 was, respectively, 2 (MAG-OM3) and 2⋅5 (rice oil) times higher compared to CoQ10 alone. There was a significant sex by treatment interaction (P = 0⋅0250) for the AUC 0-6 h supporting that in postprandial, men and women do not respond the same way to the different supplement. Women had a higher CoQ10 concentration 48 h after the single-dose intake compared to men. We conclude that CoQ10 supplements must be provided with lipids, and their kinetics is different between men and women.

Highlights

  • Coenzyme Q10 (CoQ10), known as ubiquinone, is an endogenously synthesised fat-soluble molecule

  • CoQ10 plays a major role in ATP synthesis by transporting electrons from complexes I and II to complex III via the Q cycle in the electron transport chain of the mitochondria and it contributes to the proton gradient[2,3]

  • This dose was selected because a study compared the pharmacokinetics of a single oral dose of 100 and 200 mg of CoQ10 and they reported an increase of 150 % of CoQ10 in the plasma with the 200 mg dose compared to an increase of 80 % with the 100 mg dose[18]

Read more

Summary

Introduction

Coenzyme Q10 (CoQ10), known as ubiquinone, is an endogenously synthesised fat-soluble molecule. It is composed of a benzoquinone ring and 10 isoprene subunits[1]. It has two main roles in the body. CoQ10 plays a major role in ATP synthesis by transporting electrons from complexes I and II to complex III via the Q cycle in the electron transport chain of the mitochondria and it contributes to the proton gradient[2,3]. A low level of blood CoQ10 has been reported in those with chronic diseases such as cardiovascular diseases, neurodegenerative diseases, diabetes and cancer[5,6]. During ageing, CoQ10’s blood levels tend to decrease[7,8]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call